Healthcare provider profile · identity verified

David William Wood, DO

Allopathic & Osteopathic Physicians|Family Medicine · POPLAR BLUFF, MO · NPI 1760742084

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show David William Wood, DO received $195.20 in general payments during 2025 across 9 reported records.

Lundbeck LLC accounted for 39.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Rexulti.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 282 claims for Jardiance by this doctor in 2024.

Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 54 claims for Rexulti by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$195.20

9 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lundbeck LLC	Unresolved — no canonical attribution shown	$77.08	39.5%	2	2025
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$75.40	38.6%	4	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$28.63	14.7%	2	2025
Averitas Pharma Inc.	Unresolved — no canonical attribution shown	$14.09	7.2%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Education	$152.48	6
Food and Beverage	$42.72	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
REXULTI Normalized: rexulti	Drug	Lundbeck LLC	$77.08	2	2025
Source payment records 2025-09-11 · Lundbeck LLC · $38.54 · Open Payments source 2025-10-31 · Lundbeck LLC · $38.54 · Open Payments source
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$75.40	4	2025
Source payment records 2025-03-28 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source 2025-03-28 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source 2025-11-11 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source 2025-11-11 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$28.63	2	2025
Source payment records 2025-08-13 · Amgen Inc. · $14.48 · Open Payments source 2025-11-24 · Amgen Inc. · $14.15 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$28.63	2	2025
Source payment records 2025-08-13 · Amgen Inc. · $14.48 · Open Payments source 2025-11-24 · Amgen Inc. · $14.15 · Open Payments source
QUTENZA Normalized: qutenza	Drug	Averitas Pharma Inc.	$14.09	1	2025
Source payment records 2025-07-17 · Averitas Pharma Inc. · $14.09 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	282	exact normalized	Medicare Part D
REXULTI rexulti	2025	Rexulti	2024	54 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	282	45
Lundbeck LLC Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986	Rexulti · 2024 Exact normalized brand match · 1 Part D row	54	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	841	187
Gabapentin	Gabapentin	814	147
Furosemide	Furosemide	685	133
Lisinopril	Lisinopril	662	146
Amlodipine Besylate	Amlodipine Besylate	635	142
Levothyroxine Sodium	Levothyroxine Sodium	632	123
Potassium Chloride	Potassium Chloride	620	117
Omeprazole	Omeprazole	581	115
Losartan Potassium	Losartan Potassium	548	120
Pantoprazole Sodium	Pantoprazole Sodium	517	109
Albuterol Sulfate Hfa	Albuterol Sulfate	457	108
Metoprolol Succinate	Metoprolol Succinate	436	92
Baclofen	Baclofen	423	98
Duloxetine Hcl	Duloxetine Hcl	418	65
Metoprolol Tartrate	Metoprolol Tartrate	412	74
Hydrochlorothiazide	Hydrochlorothiazide	378	81
Metformin Hcl	Metformin Hcl	351	72
Clopidogrel	Clopidogrel Bisulfate	335	79
Metformin Hcl Er	Metformin Hcl	334	77
Montelukast Sodium	Montelukast Sodium	334	53
Trazodone Hcl	Trazodone Hcl	333	66
Famotidine	Famotidine	332	53
Eliquis	Apixaban	308	57
Pravastatin Sodium	Pravastatin Sodium	308	51
Rosuvastatin Calcium	Rosuvastatin Calcium	302	57
Carvedilol	Carvedilol	298	65
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	294	45
Jardiance	Empagliflozin	282	45
Ropinirole Hcl	Ropinirole Hcl	265	47
Mounjaro	Tirzepatide	263	38
Tizanidine Hcl	Tizanidine Hcl	241	53
Sertraline Hcl	Sertraline Hcl	240	51
Tamsulosin Hcl	Tamsulosin Hcl	239	55
Meloxicam	Meloxicam	231	42
Buspirone Hcl	Buspirone Hcl	226	51
Pregabalin	Pregabalin	217	40
Spironolactone	Spironolactone	210	43
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	208	135
Fluticasone Propionate	Fluticasone Propionate	206	67
Doxycycline Hyclate	Doxycycline Hyclate	203	133
Oxybutynin Chloride Er	Oxybutynin Chloride	202	38
Ozempic	Semaglutide	193	48
Amitriptyline Hcl	Amitriptyline Hcl	180	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	171	38
Allopurinol	Allopurinol	167	35
Hydralazine Hcl	Hydralazine Hcl	157	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	151	38
Aripiprazole	Aripiprazole	147	28
Fluoxetine Hcl	Fluoxetine Hcl	141	29
Simvastatin	Simvastatin	139	34
Glipizide Er	Glipizide	134	35
Escitalopram Oxalate	Escitalopram Oxalate	132	26
Farxiga	Dapagliflozin Propanediol	131	22
Alprazolam	Alprazolam	127	23
Donepezil Hcl	Donepezil Hcl	124	23
Celecoxib	Celecoxib	119	18
Triamcinolone Acetonide	Triamcinolone Acetonide	119	74
Zolpidem Tartrate	Zolpidem Tartrate	118	15
Lovastatin	Lovastatin	117	25
Warfarin Sodium	Warfarin Sodium	117	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	112	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	111	24
Propranolol Hcl	Propranolol Hcl	107	15
Glimepiride	Glimepiride	106	21
Linzess	Linaclotide	104	30
Ventolin Hfa	Albuterol Sulfate	104	31
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	103	18
Venlafaxine Hcl Er	Venlafaxine Hcl	101	19
Methylprednisolone	Methylprednisolone	97	66
Mirtazapine	Mirtazapine	94	19
Solifenacin Succinate	Solifenacin Succinate	92	13
Fenofibrate	Fenofibrate	87	15
Ibuprofen	Ibuprofen	87	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	86	21
Dexlansoprazole Dr	Dexlansoprazole	84	14
Nystatin	Nystatin	84	36
Topiramate	Topiramate	84	13
Doxepin Hcl	Doxepin Hcl	81	18
Dicyclomine Hcl	Dicyclomine Hcl	78	16
Januvia	Sitagliptin Phosphate	78	12
Pioglitazone Hcl	Pioglitazone Hcl	78	14
Quetiapine Fumarate	Quetiapine Fumarate	78	16
Estradiol	Estradiol	75	13
Levetiracetam	Levetiracetam	75	15
Esomeprazole Magnesium	Esomeprazole Magnesium	72	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	26
Meclizine Hcl	Meclizine Hcl	72	19
Ramelteon	Ramelteon	72	13
Clonidine Hcl	Clonidine Hcl	70	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	70	18
Citalopram Hbr	Citalopram Hydrobromide	69	20
Ezetimibe	Ezetimibe	69	suppressed
Ondansetron Odt	Ondansetron	68	32
Nifedipine Er	Nifedipine	64	11
Trulicity	Dulaglutide	64	12
Vascepa	Icosapent Ethyl	64	suppressed
Symbicort	Budesonide/Formoterol Fumarate	63	14
Atenolol	Atenolol	62	11
Humalog Kwikpen U-100	Insulin Lispro	62	11
Clonazepam	Clonazepam	61	suppressed
Tresiba Flextouch U-100	Insulin Degludec	61	11
Azelastine Hcl	Azelastine Hcl	60	38
Diclofenac Sodium	Diclofenac Sodium	59	21
Myrbetriq	Mirabegron	59	13
Sumatriptan Succinate	Sumatriptan Succinate	59	suppressed
Mupirocin	Mupirocin	58	42
Ondansetron Hcl	Ondansetron Hcl	58	17
Prednisone	Prednisone	57	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	54	13
Prazosin Hcl	Prazosin Hcl	54	suppressed
Rexulti	Brexpiprazole	54	suppressed
Alendronate Sodium	Alendronate Sodium	51	12
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	51	suppressed
Naproxen	Naproxen	51	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	51	suppressed
Tramadol Hcl	Tramadol Hcl	50	22
Cephalexin	Cephalexin	48	35
Amiodarone Hcl	Amiodarone Hcl	47	13
Techlite Pen Needle	Pen Needle, Diabetic	47	16
Fluconazole	Fluconazole	46	30
Lidocaine	Lidocaine	46	17
Methocarbamol	Methocarbamol	45	13
Novolog Flexpen	Insulin Aspart	45	suppressed
Nitroglycerin	Nitroglycerin	44	17
Paroxetine Hcl	Paroxetine Hcl	44	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	34
Sucralfate	Sucralfate	43	12
Ketoconazole	Ketoconazole	42	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	suppressed
Ammonium Lactate	Ammonium Lactate	40	22
Hydroxyzine Pamoate	Hydroxyzine Pamoate	40	suppressed
Memantine Hcl	Memantine Hcl	40	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Bumetanide	Bumetanide	39	suppressed
Diazepam	Diazepam	39	11
Primidone	Primidone	39	suppressed
Synthroid	Levothyroxine Sodium	39	suppressed
Bupropion Xl	Bupropion Hcl	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Risperidone	Risperidone	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	24
Promethazine Hcl	Promethazine Hcl	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Lorazepam	Lorazepam	33	suppressed
Temazepam	Temazepam	33	suppressed
Varenicline Tartrate	Varenicline Tartrate	33	suppressed
Cefdinir	Cefdinir	31	24
Chlorhexidine Gluconate	Chlorhexidine Gluconate	31	26
Enalapril Maleate	Enalapril Maleate	31	suppressed
Sodium Chloride	0.9 % Sodium Chloride	31	suppressed
Glipizide	Glipizide	30	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	30	13
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Single Use Swab	Alcohol Antiseptic Pads	27	suppressed
Spiriva Handihaler	Tiotropium Bromide	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Colchicine	Colchicine	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	suppressed
Glyburide	Glyburide	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Levemir Flexpen	Insulin Detemir	21	suppressed
Megestrol Acetate	Megestrol Acetate	21	suppressed
Torsemide	Torsemide	21	suppressed
Brilinta	Ticagrelor	20	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	20	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Digoxin	Digoxin	19	suppressed
Flecainide Acetate	Flecainide Acetate	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Roflumilast	Roflumilast	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Azithromycin	Azithromycin	18	17
Finasteride	Finasteride	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Ramipril	Ramipril	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Budesonide Dr	Budesonide	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Naloxone Hcl	Naloxone Hcl	17	13
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Belsomra	Suvorexant	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Aimovig Autoinjector	Erenumab-Aooe	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	15	suppressed
Phenytek	Phenytoin Sodium Extended	15	suppressed
Acebutolol Hcl	Acebutolol Hcl	14	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Eszopiclone	Eszopiclone	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Progesterone	Progesterone, Micronized	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Dofetilide	Dofetilide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
M-Natal Plus	Pnv,calcium 72/Iron/Folic Acid	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Veltassa	Patiromer Calcium Sorbitex	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Motegrity	Prucalopride Succinate	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$195.20 · 9 records	Lundbeck LLC	JARDIANCE, OTEZLA, QUTENZA, REPATHA, REXULTI	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error